GlassScriptPhysician profile
Meghan N Barrett
NPI 1982392619
$2,180.76
in general payments reported to CMS, 2019-2025
21 companies · $56.93 in 2025
The $56.93 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,124 · 2025: $56.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,103 · Education: $77.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,103.48 |
| Education | $77.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $360.35 | 2023 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $302.73 | 2023 | Dupixent |
| Insmed, INC. | $274.65 | 2023 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $220.52 | 2023 | Breztri, Airsupra, Tagrisso |
| Grifols USA, LLC | $152.34 | 2023 | Prolastin-C Liquid |
| Genzyme Corporation | $118.24 | 2023 | |
| Axsome Therapeutics, INC. | $95.68 | 2023 | Sunosi |
| Janssen Pharmaceuticals, INC | $92.96 | 2023 | Xarelto |
| Mylan Specialty L.P. | $89.71 | 2023 | Yupelri |
| Inspire Medical Systems, INC. | $69.25 | 2023 | Inspire |
| Actelion Pharmaceuticals US, INC. | $61.39 | 2023 | Opsumit, Uptravi |
| Abbvie INC. | $56.93 | 2025 | |
| Glaxosmithkline, LLC. | $55.08 | 2023 | Trelegy Ellipta, Arexvy |
| Electromed, INC. | $44.31 | 2023 | Smartvest |
| Jazz Pharmaceuticals INC. | $42.61 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $38.50 | 2023 | Axert |
| Amgen INC. | $33.31 | 2023 | Tezspire |
| Merck Sharp & Dohme LLC | $24.57 | 2023 | |
| Ani Pharmaceuticals, INC. | $16.86 | 2023 | Purified Cortrophin Gel |
| Azurity Pharmaceuticals, INC. | $16.29 | 2023 | Horizant |
| Philips North America LLC | $14.48 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.